This review mainly summarizes the regulation and downstream effectors of RRAD as its dual identities in cancer genesis (Table 1 and Table 2), as well as the oncogenesis role of RRAD in senescence and current therapeutic strategy which potentially targets RRAD, thus providing a reference for future studies on the mechanisms and therapeutic developments. The gene discussed is RRAD; the disease is cancer.